.
MergerLinks Header Logo

New Deal


Announced

Completed

Coatue Management led a $220m Series C funding round in Reify Health.

Financials

Edit Data
Transaction Value£158m
Consideration TypeCash
Capital Owned-
Capital Bid For10%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

healthcare software

United States

Completed

Minority

Private Equity

Domestic

Productivity Software

Software

Venture Capital

Private

Friendly

Synopsis

Edit

Coatue Management, a global investment manager, led a $220m Series C funding round in Reify Health, a developer of cloud-based healthcare software. Other investors include ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. “Early on, we spent a number of years trying to understand this question: why is clinical research still such a devastating bottleneck on drug development? It was painfully obvious that slow, unpredictable patient enrollment was at the heart of the problem. If we want to consistently enroll trials in three to four months instead of 18 months, there are two key things we must achieve. First, we must be able to rapidly identify enough interested patients. Second, we have to make it feasible for those patients to participate in the relevant trial. We built the StudyTeam platform in 2015 to tackle the first part of that future state," Ralph Passarella, Reify Health CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US